Endocrinology & MetabolicPending review

Cushing's Syndrome

A state of cortisol excess, most often from prescribed steroids, that drives protein catabolism, gluconeogenesis and fat redistribution in patterns predictable directly from cortisol's normal actions taken too far.

In a nutshell

Cortisol excess, most often from prescribed steroids, drives protein catabolism, gluconeogenesis and central fat redistribution, producing central obesity, thin bruising skin, proximal weakness and hypertension. Diagnosis confirms excess first (dexamethasone suppression), then localises the source with ACTH.

Classic presentation

Gradual central obesity, a moon face, purple striae, proximal weakness and hypertension, often with new diabetes, in a patient on long-term corticosteroids or with an endogenous ACTH- or cortisol-secreting tumour.

Key points

  • Exogenous corticosteroid therapy is the commonest cause of Cushing's syndrome in practice: always check the drug history first.

You’ve reached the end of the preview

This topic is part of full high-yield access. Create a free account to read every key point, first-line investigation and exam trap — or browse the free sample topics without one.

Educational content pending clinical review. Not medical advice.